Cerca Biotech is a medical diagnostic company focused on bringing innovative solutions to oncology and women’s health. We strive to introduce the best tests to meet clinical needs at an affordable cost, with accuracy and rapid results at the core. Our focus is MammaTyper®, a reverse transcription-quantitative polymerase chain reaction PCR (RT-qPCR) assay and the first real innovation in breast cancer diagnostics for decades. MammaTyper® applies 21st century techniques to breast cancer subtyping, ensuring that every tissue sample is tested reliably, accurately, and quickly.